Literature DB >> 9669080

Prevention of alloxan-induced diabetes mellitus in the rat by silymarin.

C P Soto1, B L Perez, L P Favari, J L Reyes.   

Abstract

Silymarin is a free-radical scavenger and a membrane stabilizer which prevents lipoperoxidation and its associated cell damage in some experimental models. It has been proposed that lipid peroxidation caused by free radicals may be involved in alloxan-induced diabetes mellitus. Alloxan elicits pancreatic lipid peroxidation which precedes the appearance of hyperglycemia in mice. We studied the effects of silymarin on rat pancreas, the effect of this flavonoid on pancreatic, hepatic and blood glutathione (GSH) together with the pancreatic malondialdehyde concentrations in response to alloxan. On its own, silymarin increases pancreatic and blood GSH without changes in either hepatic GSH or in blood glucose. Silymarin prevents the increase in lipid peroxidation produced by alloxan. It also blunts the sustained increment in plasma glucose induced by alloxan. We suggest that silymarin has a protective effect on the pancreatic damage in experimental diabetes mellitus. This may be related to its antioxidative properties and to the increase in concentrations of plasma and pancreatic glutathione.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669080     DOI: 10.1016/s0742-8413(97)00198-9

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol        ISSN: 1367-8280


  13 in total

Review 1.  The therapeutic potential of milk thistle in diabetes.

Authors:  Christos E Kazazis; Angelos A Evangelopoulos; Aris Kollas; Natalia G Vallianou
Journal:  Rev Diabet Stud       Date:  2014-08-10

2.  Ascorbic acid is superior to silymarin in the recovery of ethanol-induced inflammatory reactions in hepatocytes of guinea pigs.

Authors:  P A Abhilash; R Harikrishnan; M Indira
Journal:  J Physiol Biochem       Date:  2013-05-08       Impact factor: 4.158

Review 3.  The use of silymarin in the treatment of liver diseases.

Authors:  R Saller; R Meier; R Brignoli
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

Review 5.  A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block.

Authors:  Nikolaos P E Kadoglou; Chrystalla Panayiotou; Michail Vardas; Nikolaos Balaskas; Nikolaos G Kostomitsopoulos; Alexandra K Tsaroucha; Georgia Valsami
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

6.  Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats.

Authors:  Shimaa M Elshazly; Amr A A Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-14       Impact factor: 3.000

7.  The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats.

Authors:  Hala O El Mesallamy; Nadia S Metwally; Mahmoud S Soliman; Kawkab A Ahmed; Mai M Abdel Moaty
Journal:  Cancer Cell Int       Date:  2011-10-31       Impact factor: 5.722

8.  Antidiabetic effect of Sida cordata in alloxan induced diabetic rats.

Authors:  Naseer Ali Shah; Muhammad Rashid Khan
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

9.  Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds.

Authors:  Cicero L T Chang; Yenshou Lin; Arlene P Bartolome; Yi-Ching Chen; Shao-Chih Chiu; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

10.  Engineered silybin nanoparticles educe efficient control in experimental diabetes.

Authors:  Suvadra Das; Partha Roy; Rajat Pal; Runa Ghosh Auddy; Abhay Sankar Chakraborti; Arup Mukherjee
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.